US Patent Issued to MICROBIOTA MED. SP. Z on June 17 for "Urolithin a and a composition containing same for external use in inflammations of various etiologies" (Polish Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,738, issued on June 17, was assigned to MICROBIOTA MED. SP. Z O.O. (Warsaw, Poland).

"Urolithin a and a composition containing same for external use in inflammations of various etiologies" was invented by Jakub Piwowarski (Umer, Poland), Sebastian Granica (Warsaw, Poland), Mariusz Sacharczuk (Warsaw, Poland) and Marek Naruszewicz (Zalesie Gome, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the compound urolithin A and its compositions for topical use in inflammatory skin conditions of various etiologies. Anti-inflammatory activity has been demonstrated in vivo in a model of inflammation of the ear caused by infiltrat...